Malignant neoplasm of the breast - Hormone replacement therapy Factor
Last reviewed for CCPS 05 October 2006.
Preliminary questions [23825]
21468 [1] there is some evidence that hormone replacement therapy may be a factor in the development of the condition under consideration.
1169 — the veteran is a woman. [2] the veteran has had hormone replacement therapy at some time. 8816 — the veteran has established the causal connection between the hormone replacement medication and VEA service for the clinical onset of malignant neoplasm of the breast. 8820 — the veteran has established the causal connection between the hormone replacement medication and eligible service for the clinical onset of malignant neoplasm of the breast. or 8819 — the veteran has established the causal connection between the hormone replacement medication and operational service for the clinical onset of malignant neoplasm of the breast. Clinical onset and operational service [8819] 8823 — the identified illness or injury, for which the veteran had hormone replacement therapy, is causally related to operational service. [7] [8] Clinical onset and eligible service [8820]
8824 — the identified illness or injury, for which the veteran had hormone replacement therapy, is causally related to eligible service. [13] [8]
Links
[1] https://clik.dva.gov.au/ccpsb019rc-16
[2] clikpopup://CCPS/reject1169No
[3] clikpopup://CCPS/reject36719No
[4] clikpopup://CCPS/reject23826No
[5] clikpopup://CCPS/reject36720No
[6] clikpopup://CCPS/reject25868No
[7] clikpopup://CCPS/reject36431No
[8] clikpopup://CCPS/reject8823,8824No
[9] clikpopup://CCPS/Had HRT for 4 years before onset of MN breast
[10] clikpopup://CCPS/reject23827No
[11] clikpopup://CCPS/reject25869No
[12] clikpopup://CCPS/reject36432No
[13] clikpopup://CCPS/reject8824No